Arca
Skip to content
Tools
Tools

-vaptan

Drugs that block vasopressin receptors, like tolvaptan.

  • Drugs ending in -vaptan: 10
  • Approved somewhere: 2
  • With a US drug page: 2

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-vaptan
Class
Drugs that block vasopressin receptors, like tolvaptan
Most common targets
AVPR2 (6), AVPR1A (4), AVPR1B (1), OXTR (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -vaptan, matched by spelling; those with a US drug page link to it.
Acts on
ConivaptanApprovedAVPR2, AVPR1AVasopressin V2 receptor antagonist
TolvaptanApprovedAVPR2Vasopressin V2 receptor antagonist
BalovaptanPhase 3AVPR1AVasopressin V1a receptor antagonist
LixivaptanPhase 3AVPR2Vasopressin V2 receptor antagonist
SatavaptanPhase 3AVPR2Vasopressin V2 receptor antagonist
BrezivaptanPhase 2——
NelivaptanPhase 2AVPR1BVasopressin V1b receptor antagonist
PecavaptanPhase 2AVPR1A, AVPR2Vasopressin V1a receptor antagonist
Mozavaptan—AVPR2Vasopressin V2 receptor antagonist
Relcovaptan—AVPR1A, OXTRVasopressin V1a receptor antagonist

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.